Mitochondrial Calcium: Effects of Its Imbalance in Disease

Abstract

Calcium is used in many cellular processes and is maintained within the cell as free calcium at low concentrations (approximately 100 nM), compared with extracellular (millimolar) concentrations, to avoid adverse effects such as phosphate precipitation. For this reason, cells have adapted buffering strategies by compartmentalizing calcium into mitochondria and the endoplasmic reticulum (ER). In mitochondria, the calcium concentration is in the millimolar range, as it is in the ER. Mitochondria actively contribute to buffering cellular calcium, but if matrix calcium increases beyond physiological demands, it can promote the opening of the mitochondrial permeability transition pore (mPTP) and, consequently, trigger apoptotic or necrotic cell death. The pathophysiological implications of mPTP opening in ischemia-reperfusion, liver, muscle, and lysosomal storage diseases, as well as those affecting the central nervous system, for example, Parkinson’s disease (PD), Alzheimer’s disease (AD), Huntington’s disease (HD), and amyotrophic lateral sclerosis (ALS) have been reported. In this review, we present an updated overview of the main cellular mechanisms of mitochondrial calcium regulation. We specially focus on neurodegenerative diseases related to imbalances in calcium homeostasis and summarize some proposed therapies studied to attenuate these diseases.

Sulfur amino acid supplementation displays therapeutic potential in a C. elegans model of Duchenne muscular dystrophy

“…These improvements appear to act largely via improved calcium handling and excitation-contraction coupling when compared to H 2 S donor compounds. As calcium dysregulation is an established phenomenon that can cause mitochondrial dysfunction 29 , SAA supplementation may act, in part, by reducing a ‘calcium-first’ mechanism of cellular degeneration in DMD, augmenting mitochondrial health as a secondary consequence.…”

Glutathione restores the mitochondrial redox status and improves the function of the cardiovascular system in old rats

“…( Sekhar et al, 2011 ; Homma and Fujii, 2015 ). In addition, the increasing of oxidative and nitrosative stress in the heart during aging and the decreasing of hydrogen sulfide (H 2 S) concentration along with a decline of a constitutive synthesis of nitric oxide (NO) collectively lead to the dysfunction of mitochondrial mechanisms, in particular to the formation of a non-selective channels—the mitochondrial permeability transition pores (mPTP) in the high-conductance mode, which is the cause of many pathological conditions ( Strutynska et al, 2016 ; Carraro et al, 2020 ; Matuz-Mares et al, 2022 ; Strutynska et al, 2022 ). Therefore, prevention of mPTP induction by inhibitors or antioxidants may be an effective way of cardioprotection.…”

Targeting N-type calcium channels in young-onset of some neurological diseases

“…The intracellular Ca 2+ level changes promote the altered neurotransmitter levels, mainly glutamate, which triggers excitotoxicity, although multiple pathogenic mechanisms like oxidative stress, neuroinflammation, and mitochondrial dysfunction, are involved in the pathogenesis of HD ( Al-Nasser et al, 2022 ). When the Ca 2+ demand increases, it also promotes the opening of the mitochondrial permeability transition pore (MPTP) and leads to apoptotic or necrotic cell death ( Matuz-Mares et al, 2022 ).…”